LEE S PHARMACEUTIC.HD-,05LEE S PHARMACEUTIC.HD-,05LEE S PHARMACEUTIC.HD-,05

LEE S PHARMACEUTIC.HD-,05

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪75.71 M‬EUR
‪1.94 M‬EUR
‪122.15 M‬EUR
‪192.87 M‬
Beta (1Y)
0.25

About LEES PHARMACEUTICAL HLDGS

CEO
Wanee Leelalertsuphakun
Headquarters
Hong Kong
Employees (FY)
‪1.06 K‬
Founded
1994
FIGI
BBG000BX7C73
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiaoyi Li in 1994 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of L1PA is 0.127 EUR — it has decreased by 3.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LEE S PHARMACEUTIC.HD-,05 stocks are traded under the ticker L1PA.
LEE S PHARMACEUTIC.HD-,05 is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
L1PA stock is 3.94% volatile and has beta coefficient of 0.25. Check out the list of the most volatile stocks — is LEE S PHARMACEUTIC.HD-,05 there?
Yes, you can track LEE S PHARMACEUTIC.HD-,05 financials in yearly and quarterly reports right on TradingView.
L1PA stock has fallen by 3.79% compared to the previous week, the month change is a 6.62% fall, over the last year LEE S PHARMACEUTIC.HD-,05 has showed a 16.99% decrease.
L1PA net income for the last quarter is ‪67.39 K‬ EUR, while the quarter before that showed ‪1.89 M‬ EUR of net income which accounts for −96.42% change. Track more LEE S PHARMACEUTIC.HD-,05 financial stats to get the full picture.
Today LEE S PHARMACEUTIC.HD-,05 has the market capitalization of ‪75.71 M‬, it has decreased by 0.36% over the last week.
LEE S PHARMACEUTIC.HD-,05 dividend yield was 1.18% in 2023, and payout ratio reached 63.38%. The year before the numbers were 1.23% and 22.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, L1PA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEE S PHARMACEUTIC.HD-,05 stock right from TradingView charts — choose your broker and connect to your account.
L1PA reached its all-time high on Mar 5, 2019 with the price of 0.857 EUR, and its all-time low was 0.127 EUR and was reached on Apr 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has ‪1.06 K‬ employees. See our rating of the largest employees — is LEE S PHARMACEUTIC.HD-,05 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LEE S PHARMACEUTIC.HD-,05 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LEE S PHARMACEUTIC.HD-,05 stock shows the sell signal. See more of LEE S PHARMACEUTIC.HD-,05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LEE S PHARMACEUTIC.HD-,05 future price: according to them, L1PA price has a max estimate of 0.12 EUR and a min estimate of 0.12 EUR. Read a more detailed LEE S PHARMACEUTIC.HD-,05 forecast: see what analysts think of LEE S PHARMACEUTIC.HD-,05 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEE S PHARMACEUTIC.HD-,05 EBITDA is ‪12.74 M‬ EUR, and current EBITDA margin is 10.43%. See more stats in LEE S PHARMACEUTIC.HD-,05 financial statements.